AndroGel Cost in Tennessee 2026: Cash Price, Insurance, Medicaid, and Cheaper Alternatives

What Is AndroGel and Why Does the Price Matter in Tennessee?

AndroGel is AbbVie's brand-name testosterone gel, approved by the FDA for adult males with hypogonadism confirmed by clinical symptoms and low serum testosterone [1]. It comes in a 1% and a 1.62% formulation applied to the shoulders and upper arms once daily. The drug has been on the U.S. market since 2000, yet its cash price remains high enough that out-of-pocket cost is the single biggest barrier to consistent treatment for Tennessee men who lack strong prescription drug coverage.

Tennessee ranks among states with higher rates of uninsured adults. According to the U.S. Census Bureau, approximately 10.1% of Tennessee residents lacked health insurance as of 2023 [2]. For those patients, a $510-per-month drug bill is prohibitive. Even men with commercial insurance frequently face a $60-to-$150 monthly copay after prior authorization, depending on the formulary tier assigned by their plan.

The Endocrine Society's 2018 clinical practice guideline specifies that testosterone therapy should be offered to men with "unequivocally low serum testosterone concentrations" confirmed on at least two separate morning measurements, alongside symptoms such as decreased libido, fatigue, and reduced muscle mass [3]. Meeting that diagnostic bar matters financially, too: insurers use guideline-concordant lab evidence as the basis for prior authorization approval.

The T-Trials, a coordinated set of seven placebo-controlled trials in 788 men aged 65 or older with testosterone <275 ng/dL, documented that testosterone gel improved sexual function, bone density, and walking distance compared to placebo over 12 months [4]. Those efficacy data underpin ongoing prescribing, but they do not reduce the sticker price at a Tennessee CVS or Walgreens.

AndroGel Cash Price at Tennessee Pharmacies in 2026

The retail cash price for a 30-day supply of AndroGel 1.62% (pump or packet) at major Tennessee pharmacy chains in 2026 sits at approximately $510 per month, consistent with AbbVie's current wholesale acquisition cost [1]. Prices vary by fewer than 5% across Memphis, Nashville, Knoxville, and Chattanooga locations based on typical retail markup practices.

GoodRx and similar discount aggregators can reduce that figure to a range of $380-to-$460 at select pharmacies for the 1% formulation, though savings on the 1.62% product are smaller because no widely dispensed generic exists for that concentration [5]. A GoodRx coupon is not insurance and cannot be combined with TennCare or most commercial plans.

Testosterone cypionate injection, a different formulation, is far cheaper at roughly $30-to-$60 per month cash-pay and shares FDA approval for hypogonadism [6]. Some patients and prescribers prefer gel for its avoidance of injection-site discomfort and smoother serum level curves, but cost-conscious patients should ask their Tennessee clinician whether injectable testosterone is clinically appropriate before paying $510 for gel.

Compounded testosterone gel prepared by a licensed 503A pharmacy in Tennessee typically runs $80-to-$120 per month, representing a potential $390-per-month saving versus brand AndroGel at list price. The legality and clinical considerations of that option are covered in detail below.

Does Tennessee Medicaid (TennCare) Cover AndroGel?

TennCare does not routinely cover AndroGel or any brand testosterone gel for male hypogonadism in the 2026 formulary year. Coverage exists only for testosterone products indicated for type 2 diabetes-related hypogonadism under certain managed care organization (MCO) contracts, and that pathway applies to a narrow subset of TennCare enrollees [7].

The three TennCare MCOs operating in 2026 are BlueCare Tennessee, UnitedHealthcare Community Plan of Tennessee, and Amerigroup Tennessee. Each maintains its own preferred drug list. None of the three lists AndroGel 1.62% as a preferred or non-preferred covered brand for the standard hypogonadism indication based on available formulary data [7].

Tennessee men enrolled in TennCare who have confirmed hypogonadism may ask their prescriber to document a medical necessity exception, but approval rates for brand testosterone gel under TennCare are low. Generic testosterone gel (1%) is listed as non-covered for the hypogonadism indication across all three MCOs as well, which means the TennCare restriction is indication-based rather than brand-based.

The American Urological Association's 2018 guideline notes that "clinicians should measure serum testosterone in patients with hypogonadal symptoms" and recommends against empiric treatment without laboratory confirmation [8]. Documenting a guideline-concordant diagnosis is the minimum requirement before any insurance exception request has a reasonable chance of success.

Is Compounded Testosterone Gel Legal in Tennessee?

Yes. Licensed 503A compounding pharmacies in Tennessee may legally prepare testosterone gel for individual patients when a valid, patient-specific prescription is written by a licensed prescriber [9]. This is distinct from FDA-approved AndroGel: compounded preparations are not FDA-approved, are not required to demonstrate bioequivalence, and cannot be marketed commercially, but they are legal when made by an appropriately licensed Tennessee pharmacy under U.S. Pharmacopeia (USP) standards.

Tennessee Board of Pharmacy rules require 503A compounders to hold a current Tennessee pharmacy license and comply with USP Chapter 795 standards for non-sterile preparations [10]. Testosterone is a Schedule III controlled substance under the Controlled Substances Act, so the compounding pharmacy must also hold a DEA registration [9].

The FDA has not placed testosterone on its "essentially a copy" enforcement list as of early 2025, meaning compounders may prepare it even when an FDA-approved product exists, provided the compounded version is customized to a specific patient's clinical need (for example, a different concentration, a fragrance-free base, or a dose not available in the commercial product) [9].

Clinically, compounded testosterone gel carries real considerations. Absorption variability between batches is a documented concern: a 2010 study published in the Journal of Clinical Endocrinology and Metabolism found that different commercial testosterone gel preparations produced meaningfully different pharmacokinetic profiles, and compounded products were not included in that comparative analysis [11]. Patients using compounded gel should have serum testosterone levels checked 4-to-6 weeks after initiation to confirm therapeutic range, typically 400-to-700 ng/dL mid-morning, per Endocrine Society targets [3].

AndroGel Insurance Coverage in Tennessee: Private Plans

Most private insurance plans sold on the Tennessee ACA marketplace and through large employers do cover testosterone gel at some formulary tier, but the pathway to coverage almost always includes prior authorization and step therapy. Step therapy commonly requires documented failure of, or contraindication to, a cheaper testosterone product such as testosterone cypionate injection before AndroGel is approved [12].

Blue Cross Blue Shield of Tennessee, one of the largest commercial carriers in the state, lists testosterone gel on its Tier 3 (preferred brand) or Tier 4 (non-preferred brand) depending on the specific plan. A Tier 3 copay for a 30-day supply typically runs $60-to-$90 with a standard deductible applied, while a Tier 4 designation can mean 30-to-50% coinsurance, pushing the patient cost toward $150-to-$250 per month [12].

Required documentation for prior authorization at most Tennessee commercial carriers includes: two serum total testosterone results below 300 ng/dL drawn on separate mornings before 10 a.m., prescriber notes documenting hypogonadal symptoms, and, at many plans, a clinical rationale explaining why injectable testosterone is not appropriate. Submitting all documentation at the initial request, rather than waiting for a denial and then appealing, cuts average approval time from 14 days to roughly 5 days based on standard payer turnaround expectations [12].

Medicare Part D plans available to Tennessee beneficiaries vary widely. Some standalone Part D plans and Medicare Advantage plans cover testosterone gel at varying cost-sharing levels; others exclude it entirely. The Medicare Plan Finder at cms.gov allows Tennessee patients to filter by drug coverage before enrolling.

AbbVie Savings Programs and Other Discount Options in Tennessee

AbbVie offers two main cost-assistance programs that Tennessee residents may use.

The myAbbVie Assist program is a patient assistance program for uninsured or underinsured patients who meet income criteria. Eligible patients may receive AndroGel at no cost. Income thresholds change annually; as of early 2025, the program was available to patients at or below 400% of the federal poverty level without adequate prescription coverage [13]. Applications are submitted through AbbVie's website or via the prescribing physician's office.

The AbbVie savings card (sometimes called the AndroGel savings card) is a co-pay assistance card for commercially insured patients only. TennCare enrollees and Medicare Part D patients are explicitly ineligible for the savings card under federal anti-kickback rules. Eligible commercially insured Tennessee patients may pay as little as $0 for a 30-day supply, subject to a maximum annual savings cap that AbbVie adjusts periodically [13].

GoodRx Gold membership, available for approximately $10 per month, may further reduce cash-pay prices at certain Tennessee pharmacy chains. Blink Health and similar platforms offer similar discount pricing. These programs work best for the 1% testosterone gel formulation where generic competition exists, rather than for AndroGel 1.62%, which remains brand-only.

The HealthRX Cost-Reduction Decision Framework for Tennessee AndroGel patients works as follows. First, confirm diagnosis with two qualifying testosterone labs to maximize insurance approval odds. Second, check your plan's formulary tier and prior-authorization requirements before filling. Third, if commercially insured, apply the AbbVie savings card before your first fill. Fourth, if uninsured, apply for myAbbVie Assist. Fifth, if uninsured and ineligible for manufacturer assistance, ask your prescriber whether a licensed 503A compounding pharmacy or generic testosterone cypionate injection is clinically appropriate. Applying this sequence in order prevents patients from paying list price unnecessarily.

Telehealth Prescribing of AndroGel in Tennessee

Tennessee law permits telehealth prescribing of Schedule III controlled substances, which includes testosterone, provided the prescriber holds a valid Tennessee medical license and has established a proper patient-provider relationship consistent with state telemedicine rules [14]. A physical examination is not mandated by Tennessee statute for testosterone prescribing via telehealth, but the prescriber must review qualifying laboratory results before prescribing, consistent with the Endocrine Society guideline requirement for two confirmatory testosterone measurements [3].

Tennessee Board of Medical Examiners Rule 0880-02-.17 governs telehealth practice standards and requires that care delivered via telehealth meet the same standard of care as in-person practice [14]. For testosterone prescribing, that means documenting symptoms, reviewing labs, discussing risks including polycythemia and cardiovascular considerations, and arranging appropriate monitoring.

The cardiovascular safety question deserves specific attention. The FDA updated AndroGel's labeling in 2015 to add a warning regarding possible increased cardiovascular risk [1]. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, found that testosterone replacement in middle-aged and older men with hypogonadism and high cardiovascular risk did not produce a significantly higher rate of major adverse cardiovascular events compared to placebo, with a hazard ratio of 1.07 (95% CI 0.94-to-1.21) [15]. That finding partially reassured clinicians, though the FDA label warning remains in place. Tennessee telehealth prescribers are expected to document this risk discussion in the medical record [14].

Several national telehealth platforms prescribe AndroGel or compounded testosterone gel to Tennessee patients. HealthRX, Defy Medical, Maximus, and others operate legally in the state. Costs through telehealth platforms vary: compounded testosterone gel is common because it reduces patient out-of-pocket expense, and some platforms include lab work and provider visits in a bundled monthly fee of $150-to-$250, which may still undercut the $510 retail price of brand AndroGel even after adding consultation costs.

Monitoring Requirements and Long-Term Cost Considerations

Starting AndroGel is not a one-time expense. The Endocrine Society recommends checking serum testosterone, hematocrit, and PSA at 3-to-6 months after initiation, then annually thereafter [3]. A standard testosterone panel at a Tennessee commercial lab (LabCorp or Quest) runs $30-to-$80 without insurance. Hematocrit is typically included in a complete blood count, adding another $25-to-$50. Patients should budget these monitoring costs into their total annual expense.

Polycythemia is the most common adverse effect requiring dose adjustment. Hematocrit above 54% triggers a dose reduction or temporary discontinuation per the Endocrine Society guideline [3]. In the T-Trials, 7.5% of testosterone-treated men versus 1.7% of placebo-treated men developed a hematocrit above 54% [4]. Early detection through routine monitoring prevents more costly interventions such as phlebotomy or emergency care.

Skin transfer to female partners or children is a boxed warning on AndroGel's FDA label [1]. Tennessee patients with young children in the household must be counseled on application site coverage and handwashing. This practical detail affects compliance: some patients switch to injections or pellets to eliminate transfer risk, which also changes the monthly cost calculation.

Long-term testosterone use suppresses endogenous testosterone production via hypothalamic-pituitary-gonadal axis feedback. Men who wish to preserve fertility should discuss the use of human chorionic gonadotropin (hCG) or clomiphene citrate as alternatives or adjuncts. A 2013 study in Fertility and Sterility (N=49) found that clomiphene citrate raised mean testosterone from 228 to 612 ng/dL in hypogonadal men while preserving sperm parameters [16]. Compounded hCG adds approximately $80-to-$150 per month to the treatment cost.

Comparing All Tennessee Options Side by Side

Brand AndroGel 1.62% costs $510 per month cash-pay at Tennessee retail pharmacies. With commercial insurance and a copay-assistance card, cost may fall to $0. With commercial insurance and no savings card, expect $60-to-$250 depending on formulary tier. TennCare covers neither the brand nor a generic for standard hypogonadism. Compounded testosterone gel from a Tennessee 503A pharmacy runs $80-to-$120 monthly. Testosterone cypionate injection (brand Depo-Testosterone, or generic) costs $30-to-$60 per month. Testosterone pellets placed subcutaneously every 3-to-6 months cost $500-to-$1,500 per procedure depending on dose and provider, or roughly $83-to-$250 per month amortized.

No single option suits every patient. A 45-year-old Tennessee man with Blue Cross commercial coverage, two qualifying labs, and a prescriber who documents step-therapy failure of injectable testosterone may obtain AndroGel for $0 via the savings card. An uninsured 55-year-old without manufacturer assistance eligibility may find compounded testosterone gel from a licensed Tennessee 503A pharmacy to be the most accessible path to treatment. Both are legal. Both require a valid prescription from a licensed clinician.

The Endocrine Society guideline states: "We recommend against making a diagnosis of androgen deficiency in men with acute or subacute illness" and specifies that confirmatory testing must occur when the patient is in stable health [3]. Testing during illness artificially lowers testosterone and can lead to unnecessary prescribing, which wastes both money and carries avoidable risk.